Patent data is one of the most detailed public records of where technology is heading and who is investing in it. Analysed well, it shows which competitors are moving into a market, where a technology field is crowded and where it is open, and which patents in a portfolio are worth maintaining. We turn that data into analysis that R&D heads, IP managers, investors and boards can act on.

What We Offer

• Patent landscape analysis. A full view of patenting activity in a technology or industry: trends, key players, portfolio focus and emerging areas.

• Competitor patent analysis. A review of rivals' portfolios to understand their technical strengths, strategic direction and possible threats or licensing opportunities.

• State-of-the-art search. An overview of the latest patents and literature in a field, for R&D teams planning new work.

• White space analysis. Areas with little or no patent activity, where new filings and products face less competition.

• Patent portfolio assessment. Evaluation of your patents for scope, enforceability, licensing potential and market relevance, to identify high-value patents, weak claims and gaps in protection.

• Technology assessment. Evaluation of an innovation's technical, commercial and IP potential to support commercialisation, licensing or investment decisions.

Our Approach

1. Start from the decision. We agree what the analysis is for, such as an acquisition, an R&D roadmap, a licensing programme or a portfolio clean-up, and shape the scope around it.

2. Collect and clean the data. We gather patent and literature data from multiple databases and remove duplicates and irrelevant records.

3. Classify and analyse. Records are grouped by technology, assignee, jurisdiction and time, using data mining and AI-assisted tools, then reviewed by analysts.

4. Visualise and recommend. Findings are presented in charts and maps, with clear recommendations rather than raw data.

Why Khurana & Khurana

• Analysts who are also patent practitioners. Our analysts understand claims and prosecution, so a portfolio assessment reflects legal strength as well as filing counts.

• Linked to commercialisation. Through our sister firm IIPRD, analytics can lead directly into licensing, valuation and commercialisation programmes.

• Results written for decision-makers. Reports are written for business audiences, with the conclusions up front.

Planning an acquisition, R&D roadmap or portfolio review?

Reach out to us at info@khuranaandkhurana.com and tell us the decision you need to make. We will propose a landscape or portfolio study scoped to it.